Pilocarpine HCl 7.5 mg Oral Tablet
RxNorm 1001004
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1001004 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pilocarpine HCl 7.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Pilocarpine hydrochloride 7.5 mg Oral Tablet
(Atom ID: 12344362)
PSNPrescribable
Prescribable Name (PSN):
Pilocarpine HCl 7.5 mg Oral Tablet
(Atom ID: 7739237)
PTPrescribable
Designated preferred name (PT):
Pilocarpine hydrochloride 7.5 mg oral tablet
(Atom ID: 12756501)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely pilocarpine hydrochloride 7.5 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12757426)
Patient Education
Pilocarpine
Pilocarpine is used to treat dry mouth caused by radiotherapy in people with head and neck cancer and to treat dry mouth in people with Sjogren's syndrome (a condition that affects the immune system and causes dryness of certain parts of the body such as the eyes and mouth). Pilocarpine is in a class of medications called cholinergic agonists. It works by increasing the amount of saliva in the mouth.
[Learn More]
* Please review the disclaimer below.